IMF-World Bank meetings to discuss restoring support for Syria, UN official says
Abdallah Dardari, assistant secretary-general for the U.N. Development Programme, told Reuters in Damascus that a roundtable on Syria hosted by the Saudi government and World Bank would take place on the sidelines of the annual meetings of the international financial bodies in Washington.
"It gives a signal to the rest of the world and to the people of Syria that you have these biggest financial institutions ready to support," he said.
Reuters reported last week that Saudi Arabia plans to pay off around $15 million in Syrian arrears to the World Bank, paving the way for millions of dollars in possible grants for reconstruction and other economic support to Syria. Sources have since told Reuters that the Saudis made the payments.
Dardari told Reuters that pay-off would allow the World Bank to support Syria through its International Development Association which provides funds for low-income countries.
"This is a big ticket item for Syria to negotiate with the World Bank. There's also the Special Drawing Rights at the IMF. Again, that's a big ticket item, in addition to all the policy and technical assistance that the Bank and the Fund can provide Syria," Dardari said.
Since former Syrian leader Bashar al-Assad was toppled last year after a nearly 14-year civil war, his successors have called on the international community to lift sanctions imposed against the country during his rule.
So far, most of those sanctions remain in place, with the United States and other Western countries saying the new authorities still need to demonstrate a commitment to peaceful and inclusive rule.
Syria has $563 million in Special Drawing Rights (SDRs) at the IMF. But using the funds requires approval by IMF members holding 85% of the total votes, giving the United States, with 16.5% of the votes, an effective veto.
Syria's finance minister, central bank governor and foreign minister are planning on attending the spring meetings next week, Reuters reported earlier this month.
It would be the first visit to the meetings by a high-level Syrian government delegation in at least two decades, and the first high-level visit by Syria's new authorities to the U.S. Assad's fall.
Washington has handed Syria a list of conditions which, if fulfilled, could lead to some sanctions relief, Reuters reported last month. Dardari said that sanctions remained "a considerable obstacle" to Syria's growth trajectory.
"Syria needs tens of billions of dollars in investments and in technical assistance and so on, and that cannot happen with such heavy sanctions imposed on the country," he said.
"So even suspension of sanctions will not be sufficient. If I were an investor and I want to invest $100 million in a power plant, I cannot take the risk of sanctions resuming next year, so sanctions have to be lifted in a comprehensive manner.
Dardari said UNDP had secured a sanctions exemption from the U.S. Treasury to mobilize up to $50 million to repair the Deir Ali power plant south of Damascus.
Three sources familiar with the issue told Reuters the World Bank is exploring hundreds of millions of dollars in grants to improve Syria's electricity grid and support the public sector.
Syria's central bank governor Abdelkader Husrieh told Reuters that his country wanted to be compliant with global financial standards but that sanctions were still "blocking the economy from going forward".
"We want to be part of the international financial system and hope that the international community will help us to remove any obstacle to this integration," he said.
(Reporting by Maya Gebeily and Timour Azhari Editing by Peter Graff)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
21 minutes ago
- Khaleej Times
IMF lifts 2025 GDP emerging economies' outlook on improved China view
The International Monetary Fund raised its outlook for economic growth across emerging market and developing economies this year to 4.1% from 3.7%, driven by frontloading and a more upbeat view on China. In an update published on Tuesday to its flagship World Economic Outlook report, the IMF also nudged its 2026 economic growth forecast for emerging economies up to 4.0% from 3.9%. China received the largest upgrade with the IMF predicting the world's number two economy would expand 4.8% this year compared with a previous forecast for 4.0%. "This revision reflects stronger-than-expected activity in the first half of 2025 and the significant reduction in U.S.–China tariffs," the IMF said, adding that the latest forecasts assumed the U.S. effective tariff rate at 17.3% rather than the 24.4%, which formed the basis of its calculations in April. The IMF also noted that for all countries "pauses on higher tariffs are assumed to remain in place past their expiration dates and higher rates are assumed not to take effect". China posted 5.2% growth in the second quarter, but cracks are showing in the export-led economy at the center of the trade war. Beijing is facing an August 12 deadline to reach a durable tariff agreement with Washington, after reaching preliminary deals in May and June. Many countries will see higher duties starting later this week. Negotiations continue Tuesday in Stockholm. Risks for the outlook are tilted downward, the IMF said, given the "precarious equilibrium of trade policy stances assumed in the baseline." The IMF said Brazil would further decelerate if additional U.S. tariffs were imposed. Growth in Latin America's largest economy is seen at 2.3% this year from 3.4% in 2024. The upgrade for emerging markets reflects a more optimistic outlook globally by the IMF, which nudged global GDP growth forecast up to 3.0% for 2025 and to 3.1% in 2026. However, those levels still mark a downgrade on the Fund's projections made in January. While most individual economies received upgrades, Russia and South Korea were the exceptions. Russia's economy is now seen expanding 0.9% this year, from a previous view of 1.5% growth. South Korea's new 0.8% GDP growth forecast for 2025 compares with 1.0% previously.
Al Etihad
an hour ago
- Al Etihad
Ozempic maker Novo's profit warning triggers $70 billion share rout
29 July 2025 19:13 COPENHAGEN (REUTERS)Investors knocked $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drugs Ozempic and Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug named Maziar Mike Doustdar as its new chief executive, turning to an experienced insider to revive sales and a share price hit by worries the company is falling behind in the weight-loss drug race it of a change at the top deepened a stock market rout, triggered after Novo slashed its outlook for 2025 sales growth to between 8% and 14%, from between 13% and 21% previously. Its shares plunged nearly 30% before paring some losses to trade down about 20% by has been hit by copycat versions of its weight-loss drugs - mixed or compounded by pharmacies. A crackdown on legal compounded versions of Wegovy in May could improve the situation, although Novo said illegal compounding Danish company said in a statement that the cut to its 2025 sales outlook was due to lower growth expectations in the second half in the United States, both for Wegovy and Ozempic in the GLP-1 diabetes drugmaker, which became Europe's most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as it looks to turn things around after the abrupt removal in May of CEO Lars Fruergaard its peak in June 2024, Novo was worth as much as $615 billion, but its shares have plunged on investor concerns about the company's experimental drug pipeline and its ability to navigate challenges in the US an Iranian-born, Austrian national, who grew up in the US, joined Novo in 1992 and will take on the new role on August currently serves as vice president for international operations, a role he took after leading the company's businesses first in the Middle East and then in Southeast Asia, Novo has lost its first-mover advantage in the United States this year to US rival Eli Lilly . The new chief executive's most urgent challenge, according to investors and analysts, is to revive Novo's performance in the US, the largest market by far for weight-loss drugs and where they are most profitable. Novo launched its weight-loss drug Wegovy nearly two and a half years before US rival Eli Lilly's Zepbound. But Zepbound prescriptions surpassed those of Wegovy this year by more than 100,000 a week.
Al Etihad
an hour ago
- Al Etihad
IMF lifts 2025 growth forecast on 'fragile' easing in trade tensions
29 July 2025 18:21 WASHINGTON (AFP)The IMF raised its global growth forecast Tuesday as efforts to circumvent US President Donald Trump's sweeping tariffs sparked a bigger-than-expected surge in International Monetary Fund still sees growth slowing this year, however, even as it lifted its 2025 projection to 3.0 percent -- up from 2.8 percent in April -- in its World Economic Outlook 2024, global growth came in at 3.3 ahead, the IMF expects the world economy to expand 3.1 percent next year, an improvement from the 3.0 percent it earlier the upward revisions, "there are reasons to be very cautious," IMF chief economist Pierre-Olivier Gourinchas told AFP."Businesses were trying to frontload, move stuff around, before the tariffs were imposed, and so that's supporting economic activity," he said."There is going to be payback for that. If you stock the shelves now, you don't need to stock them later in the year or into the next year," he means a likelihood of reduced trade activity in the second half of the year and into imposed a 10 percent levy on almost all trading partners this year, alongside steeper duties on autos, steel, and paused higher tariffs on dozens of economies until August 1, a significant delay from April when they were first and Beijing also agreed to lower for 90 days triple-digit duties on each other's goods, in a halt expiring August 12. Talks that could lead to a further extension of the truce are actions have brought the US effective tariff rate to 17.3 percent, significantly above the 3.5 percent level for the rest of the world, the IMF said. If deals unravel or tariffs rebound to higher levels, global output would be 0.3 percent down next year, Gourinchas said. Growth FiguresUS growth for 2025 was revised 0.1 percentage points up, to 1.9 percent, with tariffs anticipated to settle at lower levels than initially announced in country is also set to see a near-term boost from Trump's flagship tax and spending area growth was adjusted 0.2 percentage points higher to 1.0 percent, partly reflecting a jump in Irish pharmaceutical exports to the United States to avoid fresh European economies, Germany is still expected to avoid contraction while forecasts for France and Spain remained unchanged at 0.6 percent and 2.5 percent the IMF anticipates global inflation to keep declining, with headline inflation cooling to 4.2 percent this year, it warned that US price increases will remain above in the world's number-two economy China, however, was revised 0.8 percentage points upwards to 4.8 reflects stronger-than-expected activity in the first half of 2025, alongside "the significant reduction in US-China tariffs," the IMF said. Russia's growth was revised 0.6 percentage points down, to 0.9 percent, partially due to Russian policies but also oil prices, which are set to remain relatively subdued compared with 2024 levels, Gourinchas said.
